Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8807090 | Annales de Pathologie | 2018 | 4 Pages |
Abstract
Multiple lung carcinomas are 5 to 11,5% of lung carcinomas. The distinction between primary lung carcinomas from carcinomas with intrapulmonary metastasis is essential for optimal patient management. The histopathological analysis is very useful but it has to be completed by genotypic assessment using molecular biology (NGS). Molecular biology can also identify genetic alterations with therapeutic implications. We present the case of a patient with a history of surgery for multiple lung carcinomas diagnosed from 2013 to 2017.
Related Topics
Health Sciences
Medicine and Dentistry
Pathology and Medical Technology
Authors
Lucie Ravella, Marc Barritault, Pierre-Paul Bringuier, Lara Chalabreysse, Françoise Thivolet-Bejui, Jean-Michel Maury, Michaël Duruisseaux, Marie Brevet,